Clinical trial
Serum Glycan Analysis in Breast Cancer
NCT00897962 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Glycan Analysis in Breast Cancer
- Lead sponsor
- University of California, Davis
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- January 12, 2016
- Enrollment
- 163 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer